Cite
HARVARD Citation
Gopalakrishnan, S. et al. (2021). Integrated Mechanistic Model of Minimal Residual Disease Kinetics With Venetoclax Therapy in Chronic Lymphocytic Leukemia. Clinical pharmacology & therapeutics. 109 (2), pp. 424-432. [Online].